Systemic blockade of Clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: Results from a Phase I/II Clinical Trial - Virtakoivu, R; Rannikko, J; Viitala, M (Clin Cancer Res, 2021)
; June:OF1–OF16.